Antonia Gómez Calvo

Title: Antonia Gómez Calvo: Innovator in Pharmaceutical Compositions

Introduction

Antonia Gómez Calvo is a notable inventor based in Alcobendas, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in pain management. With a total of 3 patents to her name, her work focuses on innovative combinations of existing medications to enhance their effectiveness.

Latest Patents

One of her latest patents is a combination of ibuprofen and tramadol for relieving pain. This invention relates to a fixed-dose combination of ibuprofen, in the form of a pharmaceutically acceptable salt, and tramadol, or a pharmaceutical acceptable salt thereof. The dosage of ibuprofen in this combination ranges between 350 mg and 450 mg, while the dosage of tramadol is between 35 mg and 40 mg, expressed as the equivalent weight of tramadol hydrochloride. This combination is particularly effective for treating moderate to severe pain, whether of chronic or acute origin, and is especially beneficial for patients experiencing intense pain.

Another significant patent by Gómez Calvo is a pharmaceutical composition of ibuprofen and tramadol for ophthalmic use. This composition is designed to be effective and safe for treating ocular inflammation and/or pain associated with various diseases or pathological states affecting the eye area. Specifically, it is indicated for managing pain and/or inflammation following eye surgery.

Career Highlights

Throughout her career, Antonia has worked with various companies, including Farmalider, S.A. Her innovative approach to pharmaceutical compositions has positioned her as a key figure in the industry.

Collaborations

Antonia has collaborated with notable professionals in her field, including Fernando Martínez-Alzamora and Nuria Sanz Menéndez. These collaborations have further enriched her research and development efforts.

Conclusion

Antonia Gómez Calvo's contributions to pharmaceutical innovations, particularly in pain management, highlight her role as a significant inventor in the industry. Her patents reflect a commitment to improving patient care through effective medication combinations.